Zhizhu Kuanzhong Capsule for Patients With Functional Dyspepsia-Postprandial Distress Syndrome
A Multi-center, Randomized, Double-Blind, Placebo-Controlled Parallel Group Clinical Research of Zhizhu Kuanzhong Capsule in Treating Patients With Functional Dyspepsia-Postprandial Distress Syndrome
Sponsor: Hong Kong Baptist University
Listed as NCT04380233, this NA trial focuses on Functional Dyspepsia and remains ongoing. Sponsored by Hong Kong Baptist University, it has been updated 9 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Apr 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Apr 2022 — Apr 2024 [monthly]
Recruiting NA
-
Sep 2021 — Apr 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 4 earlier versions
-
Apr 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Not Yet Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Jun 2020 — Sep 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hong Kong Baptist University
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Kowloon Tong, Hong Kong